AMUNDI ASSET MANAGEMENT US, INC. - BIOMARIN PHARMACEUTICAL INC ownership

BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 41 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
AMUNDI ASSET MANAGEMENT US, INC. ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q1 2021$405,000
-5.6%
400,0000.0%0.00%
Q4 2020$429,000
+2.1%
400,0000.0%0.00%
Q3 2020$420,000
-14.1%
400,0000.0%0.00%
-100.0%
Q2 2020$489,000
+16.7%
400,0000.0%0.00%0.0%
Q1 2020$419,000
-0.9%
400,0000.0%0.00%
Q4 2019$423,000
+7.6%
400,0000.0%0.00%
-100.0%
Q3 2019$393,000
-5.3%
400,0000.0%0.00%
Q2 2019$415,000
-88.4%
400,000
-88.5%
0.00%
-100.0%
Q1 2019$3,567,000
+6.4%
3,487,000
+3.5%
0.01%
+66.7%
Q4 2018$3,351,000
-15.1%
3,370,000
-9.1%
0.00%
-40.0%
Q3 2018$3,949,000
-2.6%
3,706,000
-7.7%
0.01%
-16.7%
Q2 2018$4,056,000
-65.4%
4,015,000
-67.9%
0.01%
-68.4%
Q1 2018$11,736,000
-2.0%
12,501,000
+4.0%
0.02%
+5.6%
Q4 2017$11,975,000
+47.7%
12,020,000
+50.2%
0.02%
-30.8%
Q3 2017$8,105,0008,000,0000.03%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q3 2017
NameSharesValueWeighting ↓
SILVERBACK ASSET MANAGEMENT LLC 36,000,000$36,583,0005.85%
Man Investments (CH) AG 3,200,000$3,250,0002.78%
Verde Servicos Internacionais S.A. 11,000,000$11,165,0002.06%
Jabre Capital Partners S.A. 10,000,000$10,156,0001.97%
LINDEN ADVISORS LP 38,500,000$39,095,0001.39%
Opera Trading Capital 9,900,000$9,925,0001.35%
Sonora Investment Management, LLC 4,950,000$5,029,596,0000.87%
CQS Cayman LP 10,000,000$10,165,0000.68%
Polar Asset Management Partners Inc. 25,000,000$25,384,0000.51%
ADVENT CAPITAL MANAGEMENT /DE/ 26,000,000$26,383,0000.50%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders